Assessment of the Diagnostic Performance of the Detection System and Establishment of an Intelligent and Rapid Triage Model
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Coronary Heart Disease (CHD). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The rapid triage of patients with acute chest pain remains an important issue in clinical practice. This study will establish a cohort of patients suspected of acute coronary syndrome (ACS) to construct a multi-marker dynamic combined intelligent triage model. This model will triage the risk of NSTEMI in patients with chest pain at their first visit. It will also stratify the risk of patients with chest pain using major adverse cardiovascular events (MACE) within 30 days as the endpoint.
Primary outcome measures
- Myocardial infarction [Time frame: 30 days to 6 months]
Eligibility criteria
Inclusion criteria
- Adults aged 18 years or above from China, regardless of gender;
- Presence of symptoms such as chest tightness and chest pain, with the need to determine whether they are patients with acute coronary syndrome;
- Ability to obtain informed consent.
Exclusion criteria
- \- Patients with STEMI at the time of presentation;
- Patients with a clear diagnosis after tests such as troponin;
- Patients who have undergone major surgery or trauma within the past four weeks;
- Pregnant women or patients with tumors undergoing radiotherapy or chemotherapy;
- Patients who have previously participated in this study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06864676 · 2023YFC2413005 · 2023YFC2413005